Podcasts about Cardiology

Send us a textHeart Health and Spiritual Growth: A Conversation with Cardiologist Dr. Sarah RosanelIn this episode of From the Inside Out with Rivkah and Eda, we delve deep into the remarkable journey of Dr. Sarah Rosenel, a leading cardiologist who blends medical expertise with profound spiritual insights. Discover how she navigates the male-dominated field of cardiology while balancing family life, from her roots in Casablanca to her professional achievements in Miami. Learn about the importance of preventive heart health, common misconceptions, and the critical role of spirituality in medicine. This inspiring conversation also pays tribute to the late Rabbi Avraham Korf and underscores the power of kindness, faith, and perseverance in overcoming life's challenges.EPISODE SPONSORSATIDAYNU - OUR FUTURE SCHOOL This episode is generously sponsored by Atidaynu – Our Future School, a truly special place located in Brooklyn, New York, dedicated to nurturing children with unique learning needs. Atidaynu serves students with a range of challenges, including ADHD, high-functioning autism, learning disabilities, and emotional or behavioral needs.What sets Atidaynu apart is its warm, supportive, and professional environment, where every child is seen, heard, and guided with care. The school integrates evidence-based practices like the ABA (Applied Behavior Analysis) methodology and provides all related therapeutic services under one roof. Learning is individualized and highly differentiated, with hands-on materials that bring lessons to life and help each student grow at their own pace.More than just a school, Atidaynu is a community — one where passionate educators are deeply invested in their students' progress, and where growth, both academic and emotional, is celebrated every day.If you're looking to support or connect with a school that's truly making a difference in the lives of children and families, visit Atidaynu in Brooklyn and see how they're helping build brighter futures — one student at a time.Visit https://www.atidaynuourfuture.com/ to learn more and get in touch!GUEST BIODr. Sarah Rosanel, MD FACCConcierge Physician • Mentor • LeaderDr. Rosanel is a Miami‑based concierge physician specializing in internal medicine and cardiology. Born in Casablanca and raised in Paris, she completed her medical training in New York and Israel. She holds leadership roles with the American College of Cardiology and serves on the advisory boards of JOWMA, Magen David Adom, and United Hatzalah of Florida.An associate professor at Yeshiva University's Stern College and a mentor in the Solomon Leadership Program, Dr. Rosanel guides future medical professionals. As a speaker, South Florida Magazine contributor, and moderator of complex cardiac cases at the national ACC conference, she shares her expertise globally. Her honors include the Women in White Coats Heroes Award, JOWMA's Physician Leadership Award, and selection to the Cardiovascular Business Forty Under 40 Class of 2025, Dr Rosanel was also recognized as a Featured Doctor in Cardiology and Internal Medicine by Best in FlCOMMUNITYJoin the Community! Connect with us on socials to discuss Episode 101, share insights, and continue the conversations you want to have:

Approval of first-generation devices, the ticagrelor controversy, ICD longevity, the PRAGUE-25 trial (one of the most important trials of the year), and some thoughts on the end of EP as a profession are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I More Ticagrelor Controversy BMJ Investigation Finds More Concerns in Ticagrelor Trials https://www.medscape.com/viewarticle/investigation-bmj-raises-more-concerns-about-ticagrelor-2025a1000gh3 Ticagrelor PLATO study https://www.bmj.com/content/389/bmj.r1201 Ticagrelor vs Clopidogrel https://www.nejm.org/doi/full/10.1056/NEJMoa0904327 Review of the Ticagrelor Trials Evidence Base https://www.ahajournals.org/doi/10.1161/JAHA.123.031606 The Plato Trial: Do you believe in magic? https://doi.org/10.1093/eurheartj/ehp545 ONSET/OFFSET Antiplatelet Effects https://www.ahajournals.org/doi/10.1161/circulationaha.109.912550 RESPOND Study https://www.ahajournals.org/doi/10.1161/circulationaha.109.919456 II ICD Battery Longevity Variability in ICD Battery Longevity https://doi.org/10.1016/j.hrthm.2025.05.031 PRAGUE-25 Trial of AF Ablation vs LFM PRAGUE-25 Trial https://www.jacc.org/doi/10.1016/j.jacc.2025.04.042 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent surgical paper on the 'off-label' use of the Melody valve for replacement of the AV valve in small infants and children. How effective and safe was this procedure? What factors were associated with the need for reintervention and what sorts of reinterventions were most common? Why was catheter based reintervention rarely employed? What sort of anti-coagulation protocol seems best to protect these valves? Assistant Professor of Pediatrics at the University of Nebraska, Dr. Samantha Gilg shares the insights from her work this week. DOI: 10.1007/s00246-024-03538-1

Send us a textIn this episode, Dr. Eeks sits down with world-renowned cardiologist and nutrition dynamo Dr. Kim Williams to pull the lid off “healthy” plant-based restaurant meals, and a whole lot more.What's on the menu:First-of-its-kind restaurant study – How Dr. Williams scored plant-based dishes for heart health, what shocked him, and the sneaky “health halo” traps you'll now spot a mile away.Plant-based vs. junk-based – Could plant-based be sliding toward the same fate as the Western diet? He breaks down where things are headed and how to dodge the pitfalls.Cardio-nutrition deep dive – The eating plan Dr. Williams follows himself, plus straight talk on saturated fat, carbs, sugar, cholesterol, animal welfare, and factory farming.Big-picture fixes – Population-level policies he believes could actually move the needle on improving nutrition at the public health level.If you eat out, care about your heart, or just want the unvarnished science behind plant-powered plates, this episode is packed with gems you won't want to miss.Dr. Kim Allan Williams, MD, MACC, FAHA, MASNC, FESC is Chair of Medicine at the University of Louisville and a triple-threat in general, preventive, and cardiovascular-imaging cardiology. He's a former President of both the American College of Cardiology and the American Society of Nuclear Cardiology, and he previously led the Association of Black Cardiologists as Board Chair. At Wayne State he launched the Urban Cardiology Initiative, and later created Rush University's H.E.A.R.T. Program (Helping Everyone Assess Risk Today)—community screenings that pair education, nutrition, and lifestyle coaching. A lifelong advocate for nutrition literacy, health-equity, and system-wide reform, Dr. Williams has advised the FDA, CMS, and served more than 25 years as an AMA delegate. Most recently, he sat on the 2022 task force that briefed the White House Conference on Nutrition, Health, and Hunger.You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)Support the show

Tune in to learn why a CT heart scan could be your best decision for preventative care. With firsthand accounts from Tom Souligne, discover how this quick and non-invasive test played a crucial role in identifying significant heart issues.

This week Dr. Nadine Choueiter of Mount Sinai hosts a special episode of Pediheart: Pediatric Cardiology Today in which we speak with emeritus Professor of Pediatrics at the University of Toronto, Dr. Brian McCrindle about his career and life. How did he develop a love of pediatric cardiology? Who were some of his early mentors? How did he develop the international Kawasaki Disease Registry and how has he cultivated it despite minimal funding? How did he develop an interest in preventive cardiology? How can a young person make their clinical work also their academic work? Dr. McCrindle also shares some insights into navigating a successful life as well as retirement. This is a rare opportunity to be inspired by one of the great pediatric cardovascular researchers of the past 3 decades. 

This episode covers: Cardiology This Week: A concise summary of recent studies Big data in cardiology Measuring lipids: what clinicians need to know Milestones Host: Perry Elliott Guests: Carlos Aguiar, Karim Lekadir, Kostas Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/1808 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Nicolle Kraenkel and Karim Lekadir have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion. Kostas Koskinas has declared to have potential conflicts of interest to report: speaker fees / honoraria from MSD, Daiichi-Sankyo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Perry Elliott Guest: Karim Lekadir Want to watch that episode? Go to: https://esc365.escardio.org/event/1808?r Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Nicolle Kraenkel and Karim Lekadir have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson."

Unveiling Myocardial Bridges: A Hidden Cause of Heart Disease with Jeff Holden, a patient activist, author of “Imperfect Heart: Stories of Myocardial Bridges,” and host of the “Imperfect Heart” podcast. Jeff shares his harrowing personal journey with myocardial bridges, a congenital heart condition often overlooked by the medical community. Despite experiencing unexplained cardiac symptoms and undergoing multiple medical tests, Jeff was only diagnosed after a provocative test at Stanford revealed severe vasospasms and a myocardial bridge. Jeff emphasizes the importance of awareness and proper diagnosis of this condition, which can mimic common cardiovascular diseases but requires an entirely different treatment approach. The discussion highlights the need for increased recognition among primary care physicians and cardiologists, the diagnostic challenges, and the impact of this often-ignored condition on patients' lives. This episode aims to educate listeners and promote better understanding and management of myocardial bridges in the medical community.

Dr. Hoffman continues his conversation with Jeff Holden, a patient activist, author of “Imperfect Heart: Stories of Myocardial Bridges,” and host of the “Imperfect Heart” podcast.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Joan Guzmán-Bofarull, and senior author, Marta Farrero, both of the Hospital Clinic de Barcelona in Spain. They join to discuss their paper, “Regional differences in primary graft dysfunction: A report from the international consortium on PGD.” The discussion explores: The international consortium on PGD, the composition of the study, and the practices of the included countries in the United States, Canada, and Europe Hypotheses on why the study shows better 30-day and 1-year outcomes in the United States Considerations transplant centers can take regarding recipient management and donor heart selection For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Guest: Andrew Goldstone, M.D., Ph.D. On this episode of Advances in Care, host Erin Welsh talks to Dr. Andrew Goldstone, pediatric cardiac surgeon at NewYork-Presbyterian and Columbia, about the groundbreaking heart transplant that saved the lives of three separate children. It was the first time doctors at NewYork-Presbyterian Morgan Stanley Children's Hospital performed a split-root domino partial heart transplant. In this procedure, one child was transplanted with a new heart and their original heart was used to donate living pulmonary and aortic valves to two separate recipients in need. Dr. Goldstone, his colleague Dr. David Kalfa, and the rest of the team at NewYork-Presbyterian and Columbia had previous experience with a handful of domino partial heart transplants where one patient is transplanted with a new heart and another receives a valve from the explanted heart. Those experiences helped prepare for the split-root domino, which took nearly 24 hours of extremely coordinated care. In addition to their efforts to increase the number of domino heart transplants being done, physician-researchers at the institution are leading new studies that are also helping improve living valve procurement and storage, allowing more children to receive heart valves that will grow with them and require less surgeries. © 2025 …

How can health care organizations promote cardiovascular nursing leadership and practice to improve patient care and outcomes? Learn from Janette Sendin, MSN, APRN-CNS, CCNS, PCCN, of Orlando Health Orlando Regional Medical Center (recipient of the PCNA Institutional Award) about the Center's education, training, and other opportunities that can be implemented in other locations of various sizes.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Jacopo Francesco Imberti, Modena Polyclinic Modena University Hospital, Modena - Italy, Haran Burri, Cardiology Department, University Hospital of Geneva - Switzerland and Michael Glikson, Jesselson Integrated Heart Center of Shaare Zedek Medical Center, Jerusalem - Israel. In this podcast, Haran Burri, Michael Glikson, Stefan Simovic and Jacopo Imberti will discuss Conduction system pacing indications. This 2025 EHRA Cardio Talk Keep the rhythm podcast series is supported by Medtronic in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

Message our hosts, Kieran and Jose.Season 3 of The Animal Heartbeat is all about the Veterinary Cardiology Icons - those who walk among us as legends of the veterinary cardiology world.This episode features Professor Sydney Möise, of Cornell University, CV Starr Professor Emerita of Cardiology. Prof Möise's research and education output on cardiac arrhythmias has shaped how many of us think about electrical problems of the heart, and she has become known as a pioneer of ambulatory ECG assessment of heart rate variability. Her recent collaborations with Wyatt Flanders, her son, has given the veterinary cardiology world free access to dynamic and 3D Poincaré plots in dogs, broadening our understanding of conduction system disease in animals.Join our hosts, Kieran and Jose, as they discuss canine cardiac arrhythmias with a legend in their field.

In this episode of Better Edge, Sadiya S. Khan, MD, discusses the AHA's groundbreaking PREVENT-HF paradigm, which aims to implement a risk-based approach to heart failure prevention like other established methods for heart attack and stroke. Dr. Khan covers the alarming trends of heart failure prevalence in the U.S., the importance of early detection, and the integration of traditional and non-traditional risk factors in clinical practice. She also highlights how innovative strategies and emerging technologies like AI are helping shape the future of heart failure risk assessment and patient care.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Effects of Combining Coronary Calcium Score With Treatment on PlaqueProgression in Familial Coronary Artery Disease A Randomized Clinical Trial JAMA 2025. Discussion by:Guest: Michael J. Blaha, MD, MPHProfessor of Cardiology and Epidemiology and presently serves as theDirector of Clinical Research for the Johns Hopkins Ciccarone Center for thePrevention of Cardiovascular DiseaseDirector of the Cardiometabolic ClinicProgram Director for the Preventive Cardiology Fellowship.2. Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition. Alzheimer's Dement. 2025. Discussion by:Guest:Michael Devano, DO Attending Family Physician Christiana Care Health System3. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. The New England Journal of Medicine. Discussion by:Guest:Joseph Gonnella, MD Resident– Family MedicineResidency Program, Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

This is the audio version of my YouTube video "How to Match Cardiology as an IMG | Residency + Fellowship Advice".You can check the video version ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.➡️ Are you applying to the Match? Check out our match application packages ⁠⁠⁠here⁠⁠⁠.

FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I FDA News in HTN FDA announcement https://george-medicines.com/george-medicines-announces-fda-approval-of-widaplik-telmisartan-amlodipine-and-indapamide-a-new-single-pill-combination-treatment-for-hypertension-in-adults-including-initial-treatment/ Lancet Study https://doi.org/10.1016/S0140-6736(24)01744-6 JACC study vs placebo https://www.jacc.org/doi/abs/10.1016/j.jacc.2024.08.025 JAMA Cardiology Meta-analysis https://jamanetwork.com/journals/jamacardiology/fullarticle/2804313 II Invasive PE Therapy EHJ-Open review: https://academic.oup.com/ehjopen/article/5/3/oeaf071/8156689 PEITHO Trial https://www.nejm.org/doi/10.1056/NEJMoa1302097 REAL PE Observational Study https://pmc.ncbi.nlm.nih.gov/articles/PMC11308131/ III Heart Disease Trends King et al https://www.ahajournals.org/doi/10.1161/JAHA.124.038644 IV Diabetes Coverage Medscape Link https://www.medscape.com/viewcollection/37830 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with congenital heart surgeon T. Konrad Rajab of Arkansas Children's Hospital about a recent report he co-authored on piglet experiments on partial heart transplantation. How did transplanted heart valves grow in comparison to standard homografts and how did the valvular function differ with time? Is there a minimum dose of immunosuppresion that can protect these valves and can this dose be lower than full heart transplantation immunosuppresion therapy? Is partial heart transplantation considered a potential life-long approach to valve replacement or mostly something used to allow for growth of valves during childhood? What do we know about the world's limited experience in humans of this approach? Dr. Rajab shares the answers this week in an exciting 'sci-fi' episode. The future is now.https://doi.org/10.1016/j.jacbts.2024.10.015

The TCTMD news team share their h, from troponin spikes in exercise to GLP-1s in PAD, STEMI delays, and the legacy of Dimitrios Karmpaliotis.

Bob Harrington chairs a panel with two early-career physician researchers and the head of a large research institute on what the future holds in lights of NIH funding cuts. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington You may also like: Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

With Frank Flachskampf, Uppsala University, Uppsala - Sweden, and James Thomas, Northwestern University, Chicago - USA.  Link to editorial  Link to paper  

Learn how non-invasive cardiology can help diagnose and manage heart disease without surgery or major medical procedures from Dipesh M. Ludhwani, MD, medical director of non-invasive cardiology at UM Shore Regional Medical Group – Cardiology.

A big, deep dive into CTA and fractional flow reserve CT, and a sobering report on the new EVOQUE valve are discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback and Correction CRAAFT HF https://clinicaltrials.gov/study/NCT06505798 II Imaging and Behavior Change SCOT HEART 1 https://www.nejm.org/doi/full/10.1056/NEJMoa1805971 Five Reasons I Don't Believe an Imaging Test Improves Outcomes https://www.medscape.com/viewarticle/901204 SCOT HEART 2 https://www.jacc.org/doi/10.1016/j.jcmg.2024.05.016 III. More on Imaging and CT FFR Symptoms Don't Always Indicate the Severity of Coronary Artery Disease https://www.medscape.com/viewarticle/symptoms-dont-always-indicate-severity-coronary-artery-2025a1000ge6 ADVANCE Registry Protocol https://www.journalofcardiovascularct.com/article/S1934-5925(16)30288-X/abstract Research Letter JACC CV Imaging  https://doi.org/10.1016/j.jcmg.2025.05.002 ADVANCE Registry Paper 2018 https://doi.org/10.1093/eurheartj/ehy530 Cook et al JAMA Card https://jamanetwork.com/journals/jamacardiology/fullarticle/2629072 Low diagnostic yield Patel paper NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa0907272 Venk Murthy thread https://x.com/venkmurthy/status/1033379922679660544 IV EVOQUE Real World Data JACC has published a sobering research letter on the Transcatheter Tricuspid Valve Replacement called EVOQUE valve. Lupu et al JACC IV https://doi.org/10.1016/j.jcin.2025.03.019 TRISCEND II https://www.nejm.org/doi/full/10.1056/NEJMoa2401918 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with Professor Vladimiro Vida of U. Padua about a recent ECHSA large scale study assessing surgical outcomes of newborn cardiac surgery in Europe. What trends have become apparent in the past 10 years and why are outcomes generally better overall in this complex patient group? Why have outcomes for single ventricle surgery not improved as much as other newborn surgeries? Is there a relationship between center volume and outcomes? What interventions might result in improvements in outcomes of Norwood palliation? Dr. Vida provides his insights this week. https://doi.org/10.1016/j.athoracsur.2024.07.023

Host: Denise M. Dupras, M.D., Ph.D. Guest: John R. Giudicessi, M.D., Ph.D. Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi's insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Nikil Prasad, MD, a cardiology fellow in the Columbia University Medical Center in New York, to discuss the paper, “Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1.” The discussion explores: The study's subdivisions of CAV grade 1 into CAV 1a and CAV 1b, based on the degree of coronary stenosis Differing clinical information provided by different methods of CAV screening: reduced myocardial blood flow reserve vs angiographic grading Limitations in implementing PET-based CAV assessments at various centers, and how transplant programs can use combined testing data For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Host: Susanna Price Guest: Sabiha Gati Want to watch that extended interview on LDL management? Go to: https://esc365.escardio.org/event/1809?resource=interview Want to watch the full episode? Go to: https://esc365.escardio.org/event/1809   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails.   Declarations of interests Stephan Achenbach, Sabiha Gati, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Heart disease risk: Framingham Heart Study insights Sudden death in female athletes Mythbusters: Owning a pet reduces the risk of heart disease Host: Susanna Price Guests: Carlos Aguiar, Sabiha Gati, Vasan Ramachandran Want to watch that episode? Go to: https://esc365.escardio.org/event/1809 Want to watch that extended interview on sudden death in athletes? Go to: https://esc365.escardio.org/event/1809?resource=interview   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. The ESC is not liable for any translated content of this video.The English-language always prevails. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Sabiha Gati, Nicolle Kraenkel, Susanna Price and Vasan Ramachandran have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In this podcast, Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure (HF) with mildly reduced or preserved ejection fraction, including:The emerging role of mineralocorticoid receptor antagonists in HF careFinerenone's efficacy in reducing composite cardiovascular death and worsening HF events Why safety must be monitored, especially considering hyperkalemia riskWhere HF guideline recommendations lack compared with the current evidence PresenterTy J. Gluckman, MD, MHAMedical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS)Providence Heart InstituteProvidence Health SystemPortland, OregonProgram page: https://bit.ly/448XcH0

Healthcare advocacy takes place in the clinic setting and in legislative chambers, and impacts the access patients have to needed therapies. Hear from Dharmesh Patel, MD, President of Partnership to Advance Cardiovascular Health (PACH) about the Inflation Reduction Act, the MINI-Act, and being the voice for the voiceless--our patients.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tuesday, June 17-  Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health.First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with a focus on the MIND diet and what it can do for anyone concerned about getting dementia, why the Mediterranean Diet tends to be a foundation for most heart-healthy diets, and why eating beans is beneficial for your health (and a deep dive into why beans are considered the “musical fruit”). Some of the brain-healthy food groups for the MIND Diet are green leafy vegetables, nuts, berries, beans, cold water fatty fish, and olive oil.Next up, why exercise is as important as proper diet and nutrition, a new study shows exercise can be more beneficial than drug intervention for recurrent colorectal cancer, and post menopausal women are at an increased risk for heart disease and why eating mango can help lower the risk of dying from heart disease.Then, diving into why nightshades, including tomatoes, have great antioxidants properties, but not everyone can tolerate nightshade fruits and vegetables.The conversation shifts to the sleep habits of children and how it correlates to a happy family. Yes, a well-slept family is happier — and a happy family gets better sleep with research supporting a strong bidirectional relationship between family happiness and quality sleep.Lastly, Dr. Ken and Doug refer to a conversation from last week's Good Day Health program with Dr. Jack, where Jack said improper supplement brands do nothing but harm your liver and other organs — stating supplements from natural ingredients are far superior than synthetic supplements. Dr. Ken's answer is more about everything in moderation, and why too much of the synthetic supplements can be harmful, but are not inherently harmful. Website: GoodDayHealthShow.comSocial media: @GoodDayNetworks

The first electrocardiograph was invented in 1895. That device looked a lot different from today’s machines, and there are some other contenders for the title of “first.” Research: AlGhatrif, Majd, and Joseph Lindsay. “A brief review: history to understand fundamentals of electrocardiography.” Journal of community hospital internal medicine perspectives vol. 2,1 10.3402/jchimp.v2i1.14383. 30 Apr. 2012, doi:10.3402/jchimp.v2i1.14383 Baldassarre, Antonio et al. “The Role of Electrocardiography in Occupational Medicine, from Einthoven's Invention to the Digital Era of Wearable Devices.” International journal of environmental research and public health vol. 17,14 4975. 10 Jul. 2020, doi:10.3390/ijerph17144975 Browne, Sir Thomas. “Chap. IV: Of Bodies Electrical.” From Pseudodoxia Epidemica. 1672. https://penelope.uchicago.edu/pseudodoxia/pseudo24.html Case Western Reserve. “Cambridge Electrocardiograph, 1920.” https://artsci.case.edu/dittrick/online-exhibits/explore-the-artifacts/cambridge-electrocardiograph-1920/ Fisch, Charles. “Centennial of the string galvanometer and the electrocardiogram.” Journal of the American College of Cardiology. Volume 36, Issue 6, 15 November 2000. https://www.sciencedirect.com/science/article/pii/S0735109700009761 Friedman, Paul A. “The Electrocardiogram at 100 Years: History and Future.” Circulation. Volume 149, Number 6. https://doi.org/10.1161/CIRCULATIONAHA.123.065489. Fye, W. Bruce. “A History of the Origin, Evolution and Impact of Electrocardiography.” The American Journal of Cardiology. Vol. 73, No. 13. 5/15/1994. Goodrich, Joanna. “Forget Electrodes, the First EKG Machine Used Buckets of Saline Solution and Telephone Wire.” IEEE Spectrum. 1/5/2021. https://spectrum.ieee.org/forget-electrodes-the-first-ekg-machine-used-buckets-of-saline-solution-and-telephone-wire Howell, Joel D. “Early Perceptions of the Electrocardiogram: From Arrythmia to Infarction.” Bulletin of the History of Medicine, SPRING 1984, Vol. 58, No. 1. Via JSTOR. https://www.jstor.org/stable/44441681 Jenkens, Dean and Dr Stephen Gerred. “A (not so) brief history of electrocardiography.” ECG Library. 2009. https://ecglibrary.com/ecghist.html Macfarlane PW, Kennedy J. Automated ECG Interpretation—A Brief History from High Expectations to Deepest Networks. Hearts. 2021; 2(4):433-448. https://doi.org/10.3390/hearts2040034 Rautaharju, Pentti M. “Eyewitness to history: Landmarks in the development of computerized electrocardiography.” Journal of Electrocardiology 49 (2016) 1 – 6. Rivera-Ruiz, Moises et al. “Einthoven's string galvanometer: the first electrocardiograph.” Texas Heart Institute journal vol. 35,2 (2008): 174-8. Salam, Amar M. “The Invention of Electrocardiography Machine.” HeartViews. 2019 Nov 14;20(4):181–183. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_102_19. Vincent, Rony. “From a laboratory to the wearables: a review on history and evolution of electrocardiogram.” Iberoamerican Journal of Medicine, vol. 4, núm. 4, pp. 248-255, 2022. https://www.redalyc.org/journal/6920/692072548011/html/ See omnystudio.com/listener for privacy information.

Message our hosts, Kieran and Jose.Our Animal Heartbeat live panel discussion in 2025 covers the topic of artificial intelligence and its use in veterinary and human patients. Our panel review topics such as how to validate AI tools, where AI fits in current medicine and how opportunities for its use are evolving, and should we worry about AI?Our hosts Kieran and Jose are joined by a fantastic panel of guests:Professor Virginia Luis Fuentes; Professor of Veterinary Cardiology, Royal Veterinary CollegeProfessor Anurag Agarwal; Professor of Aeroacoustics, University of CambridgeDr Matthew Shun-Shin; Consultant Cardiologist, Imperial College LondonCatherine Stowell; Imperial College London and founder of The Animal Ultrasound AssociationThis episode was recorded live at Emmanuel College, Cambridge, as part of the 2025 Cambridge Festival of podcasts.

Listener feedback on cardiac sarcoidosis, SA node ablation, surgical AF ablation, chronic kidney disease protection, and recruiting for clinical trials are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback EHJ paper Mathijssen et al https://doi.org/10.1093/eurheartj/ehaf338 Nordenswan et al https://www.ahajournals.org/doi/full/10.1161/CIRCEP.117.006145#tab-contributors II IST HR Case Reports https://doi.org/10.1016/j.hrcr.2025.05.017 Lakkireddy et al https://doi.org/10.1016/j.hrthm.2021.07.010 III Survival After Surgical AF ablation during CABG McClure et al https://doi.org/10.1093/europace/eux336 Schaffer et al https://doi.org/10.1016/j.athoracsur.2025.03.044 IV Finerenone with Empagliflozin in CKD and DM The Confidence Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2410659 V Recruiting for Important Trials and the Stature of EP as a Profession Two UK Cardiology Trials Struggle to Recruit Patients https://www.medscape.com/viewarticle/two-uk-cardiology-trials-struggle-recruit-patients-2025a1000ffs CRAFT HF https://clinicaltrials.gov/study/NCT06505798 BRITISH https://doi.org/10.1016/j.ahj.2023.09.008 PROFID https://profid-project.eu/profid-ehra-trial/ You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with Assistant Professor of Pediatrics at Harvard Medical School, Dr. Audrey Dionne about a recent work she co-authored on the topic of outcomes of ablation in the early postoperative period following congenital heart surgery. Who is a candidate for this intervention and what were the outcomes? How commonly were serious complications encountered and how successful were these procedures? Dr. Dionne reviews these and other aspects of this novel review this week. https://doi.org/10.1016/j.hrthm.2024.08.061

Most cardiologists wait until you're having a heart attack to intervene. Dr. Michael Twyman, a board-certified cardiologist and founder of Apollo Cardiology, is flipping that script entirely. In this groundbreaking episode, Dr. Twyman reveals why conventional cardiology is missing the real root causes of heart disease and how quantum biology, mitochondrial health, and circadian rhythms are the future of cardiovascular medicine. Dr. G and Dr. Twyman dive deep into: – Why nitric oxide is your heart's most critical molecule (and how to optimize it naturally) – The glycocalyx: your blood vessel's protective coating that most doctors ignore – How your oral microbiome directly impacts your cardiovascular health – Why grounding and sunlight are essential for heart health – The cutting-edge labs your cardiologist probably isn't ordering – How to spot early signs of heart disease decades before symptoms appear. This isn't about cholesterol and cardio. This is about understanding your heart as an electrical, quantum system that thrives on light, movement, and proper fuel. Dr. Twyman shares practical protocols for optimizing mitochondrial function, supporting endothelial health, and preventing cardiovascular disease at the cellular level. If you want to live longer and stronger, this episode will completely reframe how you think about heart health. #hearthealth #cardiology #mitochondria Dr. Michael Twyman Website: drtwyman.com Instagram: @dr.twyman Timestamps:  00:00 - Heart Health Beyond Cholesterol & Cardio 02:06 - Proactive vs Reactive Cardiology 05:15 - Lipoproteins: The Real Heart Disease Markers 12:17 - Nitric Oxide: Your Heart's Master Molecule 21:04 - Mitochondrial Health & Heart Function 25:25 - Glycocalyx: Your Blood Vessel's Protective Coating 29:14 - Sleep, Stress & Cardiovascular Health 36:27 - Travel Protocols for Heart Health 39:16 - Best Foods for Heart & Blood Vessels 43:33 - Carnivore Diet & Heart Health Risks 47:24 - Final Heart Health Recommendations Hosted by Doctor Christian Gonzalez N.D. Follow Doctor G on Instagram @doctor.gonzalez https://www.instagram.com/doctor.gonzalez/ Sign up for our newsletter! https://drchristiangonzalez.com/newsletter/

In this episode of Health Matters, we discuss what causes dizziness with Dr. Louise Klebanoff, a neurologist with NewYork-Presbyterian and Weill Cornell Medicine. Dr. Klebanoff explains the different types of dizziness, such as lightheadedness, vertigo, and gait instability. We also cover how to differentiate between these types, the potential causes, and  when to seek medical attention.___Dr. Louise Klebanoff, MD has been named the Chief of General Neurology and the Vice Chair of Operations for the Department of Neurology at Weill Cornell Medical College. She is also an Assistant Attending Neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.  Dr. Klebanoff received her medical degree from Georgetown University Medical Center, graduating first in her class, and went on to complete a residency in Neurology and a fellowship in Critical Care Neurology at NewYork-Presbyterian Hospital/Columbia University Medical Center.Prior to joining the Weill Cornell faculty, Dr. Klebanoff served as Attending Neurologist at Beth Israel Medical Center, where she also held leadership roles on various committees and served as the first female president of the Medical Board.Dr. Klebanoff is board certified in Psychiatry and Neurology. She is a member of the Alpha Omega Alpha honor society, the American Medical Association and the American Academy of Neurology.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

Amanda Kallen is an associate professor in the Division of Reproductive Endocrinology and Infertility at the University of Vermont Larner College of Medicine and an adjunct professor at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.N. Kallen and Others. Undermining Women's Health Research — Gambling with the Public's Health. N Engl J Med 2025;392:2185-2187.

Dr. Jane Wilcox, Associate Chief of Cardiology, Northwestern Medicine Bluhm Cardiovascular Institute, joins Lisa Dent to discuss men’s health. June is Men’s Health Month, and heart disease is the number one killer of men. Dr. Wilcox shares information about the disease, and encourages people to talk to the men in their life about getting regular screening and […]

Send us a textPatent Ductus Arteriosus in Preterm Infants.Ambalavanan N, Aucott SW, Salavitabar A, Levy VY; Committee on Fetus and Newborn; Section on Cardiology and Cardiac Surgery.Pediatrics. 2025 May 1;155(5):e2025071425. doi: 10.1542/peds.2025-071425.PMID: 40288780 Review.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Listener feedback on cardiac sarcoidosis, out-of-hospital cardiac arrest, less is more when it comes to post-stent antiplatelets, lipoprotein(a), and atrial fibrillation in HFpEF are discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Mathijssen https://doi.org/10.1093/eurheartj/ehaf338 Poyhonen https://doi.org/10.1161/CIRCEP.124.013239 II News in out of hospital cardiac arrest AHA Press Release https://newsroom.heart.org/news/nfl-safety-justin-reid-expands-cpr-education-for-youth-through-summer-program Chan et al https://www.ahajournals.org/doi/abs/10.1161/CIRCOUTCOMES.124.011799 III Post-Stent Antiplatelet 4D ACS trial https://eurointervention.pcronline.com/article/one-month-dual-antiplatelet-therapy-followed-by-prasugrel-monotherapy-at-a-reduced-dose-the-4d-acs-randomised-trial IV Lp(a) and the new PREVENT equation for Predicting cardiac events Aug 02, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1001429 Bhatia et al https://jamanetwork.com/journals/jamacardiology/fullarticle/2835022 V AF in HFpEF Saksena et al https://doi.org/10.1093/europace/euad095 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we venture back in time to 2023 to review the results of the update of the Single Ventricle Reconstruction trial, specifically SVR III. How are HLHS patients are faring post Norwood at age 12? What is the overall transplant-free survival rate in this group? Are there differences in survival seen at 12 years between BTTT shunt patients and RV-PA conduit shunt patients? How do they compare in exercise capabilities? What about rates of PLE or arrhythmias seen? Are there interventions that may improve outcomes going forward? These are amongst the questions reviewed this week with the first author, Dr. Caren Goldberg who is Professor of Pediatrics at the University of Michigan. DOI: https://doi.org/10.1161/circulationaha.123.065192

Can pills and powders really improve our health? Despite their clinical look, most supplements aren't tested with the scientific rigour we expect from medical treatments, and many don't live up to their promises. Today, we're joined by two of ZOE's top scientists to uncover the truth. They share groundbreaking new research and reveal the results of a brand new randomized controlled trial that could reshape how we think about supplements and introduce an entirely new kind. Tim Spector is one of the world's top 100 most cited scientists, a professor of epidemiology, and ZOE's scientific co-founder. He's joined by Dr. Sarah Berry, a world leading expert in large scale human nutrition studies, Professor of Nutrition at King's College London, and Chief Scientist at ZOE. By the end of this episode, you'll have the latest science to help you make informed decisions about supplements and understand what your gut health really needs in 2025. Unwrap the truth about your food

The white-coat effect is a measure of blood pressure change from before to during the visit in office/clinic when the blood pressure is recorded by a physician or nurse; this was first described in 1983 by Mancia et al, and was initially thought to represent a benign process. But it was unclear what this actually meant for pregnancy. Ambulatory blood pressure monitoring (ABPM) has been used in pregnancy for about 20 years now. Use of this monitoring option has revealed a subgroup of patients who have persistently high blood pressure (BP) in the presence of health care providers, but a normal ambulatory or self-measured BP. This phenomenon has been termed “White Coat Hypertension” (WCH). In 2013, The International Society for the Study of Hypertension in Pregnancy (ISSHP) published the revised classification for hypertensive disorders in pregnancy, that included WCH, not previously included. The ISSHP guidelines also emphasize that a diagnosis of white coat hypertension in pregnancy should only be considered before 20 weeks of gestation. We now know that WCH, outside of pregnancy, is not an entirely benign process. The role of metabolic risk factors in patients with white-coat hypertension was first outlined in 2000 by Kario and Pickering. When metabolic risk factors are present in association with white-coat hypertension, the increased risk of target organ damage is determined not only by the blood pressure characteristics but also by the metabolic abnormalities. Recognizing the potential risks of white coat hypertension was also published in a commentary in 2016 out of the European Society of Cardiology. That article's title was, “White-coat hypertension: not so innocent”. But what is the latest data on WCH in pregnancy? Is WCH linked to poor obstetrical outcomes? Does WHC need medication therapy? We have data from 2024 to help us. Listen in for details.

What if your heart was the key to not only healing your life—but healing the world? In this powerful episode of The You-est You® Podcast, I'm joined again by my friend, Dr. Rollin McCraty, Director of Research at HeartMath Institute, for a conversation that bridges science and spirit. We dove deep into the science of heart intelligence, the different types of intuition, and how your heart is actually the bridge to your higher self.  You'lll not want to miss the gems dropped in this episode about the incredible power of your heart!  Here's to remembering how powerful your heart really is! Learn more: get Dr. McCraty's book Heart Intelligence now here: https://amzn.to/4kmR6d5    About Dr. Rollin McCraty Dr. Rolling McCraty, Ph.D. is the Executive Vice President and Director of Research at the HeartMath Institute, where he has been a pivotal figure since its inception in 1991. A renowned psychophysiologist and professor at Florida Atlantic University, Dr. McCraty specializes in the study of heart-brain communication, heart rate variability, and the physiological impacts of emotions on health and cognition.  His groundbreaking research has led to the development of tools and technologies aimed at enhancing emotional self-regulation, resilience, and overall well-being. As a principal architect of the Global Coherence Initiative, Dr. McCraty explores the interconnectedness between human consciousness and Earth's magnetic fields, emphasizing the heart's role in fostering global harmony.  Dr. McCraty's work has been featured in numerous scientific journals, including the American Journal of Cardiology and Biological Psychology, and he has appeared in various media outlets and documentaries such as I Am and The Power of the Heart. Enjoy this conversation with Dr. Rollin McCraty! About Your Host, Julie Reisler Join Julie Reisler weekly, podcast host, intuitive coach, author, and multi-time TEDx speaker, each week to learn how to access your spiritual gifts and inner guidance to be your You-est You® and achieve greater inner peace, spiritual connection, happiness, and abundance. Tune in to hear powerful, inspirational stories and wisdom from spiritual luminaries, experts, conscious leaders, psychic mediums, and extraordinary human beings that will help to transform your life.  Be sure to subscribe to Julie's YouTube channel https://www.youtube.com/juliereisler and ring the notification bell so that you never miss a powerful episode! Here's to your truest, You-est You! Love, Julie   You-est You® Resources for YOU! See below for free tools, resources, programs, and goodies to help you become your YOU-EST YOU!   FREE Manifest Your Goals & Dreams 7-Day Toolset This stunning free toolset is a 7-day workbook (25 pages full) of powerful mindset practices, grounding meditations (and audio), a new beautiful time management system and template to set your personalized schedule for your best productivity, a personalized energy assessment, and so much more. It was designed to specifically help you uplevel your routine and self-care habits for success so you can radiate and become your ‘You-est You'. These tools are some of Julie's best practices used with hundreds of her clients to help you feel more confident, clear, and connected to your best self so that you feel inspired to take on the world. Get it at: juliereisler.com/toolset   FREE Intuition Test Unlock your unique intuitive super-powers and discover your dominant Intuition Language™. Take the free test now at https://juliereisler.com/intuitiontest-podcast   Intuition Activation Mini-Course - 90% OFF! For a limited time only, get access to Julie's powerful transformative Intuition Activation mini-course for 90% off! You'll have lifetime access to this course that is full of video modules, worksheets, meditations, tools and practices to unlock your intuition and activate your inner guidance! Sign up now at https://juliereisler.com/activation    Julie's Private Soul Circle Membership on YouTube is Here! If you've been craving a deeper connection to your intuition, spiritual guidance, and heart-centered community, this is your invitation.

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback II CRT vs CSP – CONSYST-CRT • Trial JACC EP https://doi.org/10.1016/j.jacep.2025.03.024 III The Important QRS • Kewcharoen et al https://www.ahajournals.org/doi/10.1161/CIRCEP.125.013809 IV ABYSS Trial of BB Interruption after MI Continues to be Mis-interpreted • ABYSS Main https://www.nejm.org/doi/full/10.1056/NEJMoa2404204 • ABYSS substudy https://doi.org/10.1093/eurheartj/ehaf170 • REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479 V Oral PCSK9i and the PURSUIT Trial • Koren et al https://www.jacc.org/doi/10.1016/j.jacc.2025.03.499 • Editorial https://doi.org/10.1016/j.jacc.2025.03.518 • Is Lifelong LDL-C Lowering Within Reach? The heart-1 Gene-Editing Trial https://www.medscape.com/viewarticle/998162 • Heart-1 Gene Therapy Trial Pauses Enrollment https://www.medscape.com/viewarticle/998162 • EHJ coverage VERVE https://academic.oup.com/ehjcvp/article/10/2/87/7455877 VI Cardiac Sarcoidosis and Risk of VT • EHJ paper Mathijssen et al https://doi.org/10.1093/eurheartj/ehaf338 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

In this episode, Ben breaks down the science-backed, day-by-day timeline of what happens to your body when you walk just 30 minutes a day. Learn how this simple habit can lower blood sugar, shrink belly fat, improve digestion, boost mood, enhance insulin sensitivity, and even reduce your risk of death by up to 50%.

Listener feedback on sports “disqualification,” big digoxin news, Brugada syndrome, another positive finerenone study, and unblinded transcatheter trials are discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback JACC EP Paper https://www.jacc.org/doi/10.1016/j.jacep.2025.03.013 II Digoxin News DIGIT HF Baseline Characteristics paper https://doi.org/10.1002/ejhf.3679 DIGIT HF Rationale paper https://pmc.ncbi.nlm.nih.gov/articles/PMC6607489/ Dig trial https://www.nejm.org/doi/full/10.1056/NEJM199702203360801 DECISION trial https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3428 Ziff et al BMJ meta-analysis https://www.bmj.com/content/351/bmj.h4451 III Brugada Syndrome Gomes et al https://doi.org/10.1093/europace/euaf091 IV Another Finerenone Substudy Published FINEARTS-HF trial substudy, Bhatt, A et al https://doi.org/10.1016/j.cardfail.2025.05.006 FINEARTS HF Main paper https://www.nejm.org/doi/full/10.1056/NEJMoa2407107 TOPCAT https://www.nejm.org/doi/full/10.1056/NEJMoa1313731 TOPCAT regional variation Circ paper https://www.ahajournals.org/doi/10.1161/circulationaha.114.013255 V Another Opinion on Unblinded Transcatheter Intervention Trials Kaul https://eurointervention.pcronline.com/article/unblinded-trials-of-transcatheter-interventions-with-subjective-endpoints-what-are-the-implications You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net